SCHEMBL3845787

SCHEMBL3845787

OCCCCC1CCN(c2ncnc3ccc(-c4c[nH]nc4-c4ccc(F)cc4)cc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 11/20 0.45
HPGD P15428 3/20 0.45
CYP1A2 P05177 11/20 0.45
CYP2C19 P33261 9/20 0.45
ALDH1A1 P00352 9/20 0.45
CLK4 Q9HAZ1 8/20 0.45
USP2 O75604 4/20 0.45
LMNA P02545 7/20 0.44
TSHR P16473 7/20 0.44
HIF1A Q16665 7/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
CYP2D6 P10635 4/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 6/20 0.43
TP53 P04637 2/20 0.43
DYRK1A Q13627 1/20 0.42
ENPP1 P22413 2/20 0.42
HSD17B10 Q99714 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849667 0.85 CYP3A4 (0.50) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3844703 0.81 CYP3A4 (0.47) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3848419 0.81 CYP3A4 (0.63) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3848700 0.80 CYP3A4 (0.48) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3845114 0.80 CYP3A4 (0.52) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3850556 0.80 LRRK2 (0.52) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3849819 0.79 ACHE (0.50) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3849281 0.78 PAK1 (0.53) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
Hydrochloric Acid SCHEMBL3849032 0.78 AKT1 (0.51) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1
SCHEMBL3847688 0.78 CYP3A4 (0.42) CYP3A4HPGDCYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed